Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Eschmann, Susanne-Martina

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. [electronic resource] - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Feb 2005 - 253-60 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Validation Study

0161-5505


Carcinoma, Non-Small-Cell Lung--diagnostic imaging
Cell Hypoxia
Female
Fluorine Radioisotopes
Germany--epidemiology
Head and Neck Neoplasms--diagnostic imaging
Humans
Incidence
Lung Neoplasms--diagnostic imaging
Male
Middle Aged
Misonidazole--analogs & derivatives
Neoplasm Recurrence, Local--diagnostic imaging
Positron-Emission Tomography--statistics & numerical data
Prognosis
Radiopharmaceuticals
Reproducibility of Results
Sensitivity and Specificity
Treatment Outcome